RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.33%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$5.05B
AUM Growth
+$5.05B
(+10%)
Cap. Flow
+$474M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
165
New
13
Increased
67
Reduced
10
Closed
9
Top Buys
| 1 |
Agilon Health
AGL
|
$284M |
| 2 |
LENZ
LENZ Therapeutics
LENZ
|
$66.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$58M |
| 4 |
Lifestance Health
LFST
|
$41.8M |
| 5 |
NeueHealth
NEUE
|
$40.8M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$100M |
| 2 |
AstraZeneca
AZN
|
$32.3M |
| 3 |
Inspire Medical Systems
INSP
|
$20.7M |
| 4 |
Atea Pharmaceuticals
AVIR
|
$19.4M |
| 5 |
UnitedHealth
UNH
|
$14M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Consumer Staples | 1.63% |
| 3 | Industrials | 0.72% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Agilon Health
AGL
$530M
| $284M | 5.61% | +6,999,023 | New | +$284M |
|
2
Zai Lab
ZLAB
$3.68B
| $179M | 3.55% | 1,014,000 +80,500 | +9% | +$14.2M |
|
3
Agios Pharmaceuticals
AGIO
$2.19B
| $142M | 2.8% | 2,574,308 +30,708 | +1% | +$1.69M |
|
4
Humana
HUM
$36.5B
| $134M | 2.65% | 302,500 +1,500 | +0.5% | +$664K |
|
5
Align Technology
ALGN
$10.3B
| $115M | 2.27% | 187,750 +10,250 | +6% | +$6.26M |
|
6
Idexx Laboratories
IDXX
$51.8B
| $114M | 2.25% | 180,000 | – | – |
|
7
Insulet
PODD
$23.9B
| $112M | 2.22% | 408,750 +37,750 | +10% | +$10.4M |
|
8
Intuitive Surgical
ISRG
$170B
| $110M | 2.18% | 120,000 | – | – |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $98.8M | 1.95% | 1,015,000 | – | – |
|
10
Novavax
NVAX
$1.21B
| $96.6M | 1.91% | 455,000 -6,000 | -1% | -$1.27M |
|
|
11
UnitedHealth
UNH
$281B
| $96.1M | 1.9% | 240,000 -35,000 | -13% | -$14M |
|
12
argenx
ARGX
$43.6B
| $94.8M | 1.87% | 315,000 +15,000 | +5% | +$4.52M |
|
13
Immunocore
IMCR
$1.62B
| $93.5M | 1.85% | 2,394,785 +102,500 | +4% | +$4M |
|
14
HCA Healthcare
HCA
$94.5B
| $93M | 1.84% | 450,000 | – | – |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $88M | 1.74% | 531,000 +46,000 | +9% | +$7.63M |
|
16
Freshpet
FRPT
$2.72B
| $82.5M | 1.63% | 506,500 | – | – |
|
|
NVTA
17
DELISTED
Invitae Corporation
NVTA
| $77.6M | 1.53% | 2,302,032 +88,055 | +4% | +$2.97M |
|
|
BPMC
18
DELISTED
Blueprint Medicines
BPMC
| $71.1M | 1.41% | 808,860 +62,128 | +8% | +$5.46M |
|
19
Exact Sciences
EXAS
$8.98B
| $70.9M | 1.4% | 570,000 | – | – |
|
|
ONC
20
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $68.6M | 1.36% | 200,000 | – | – |
|
|
LENZ
21
LENZ Therapeutics
LENZ
$1.1B
| $66.1M | 1.31% | +2,151,738 | New | +$66.1M |
|
22
Aclaris Therapeutics
ACRS
$209M
| $66.1M | 1.31% | 3,762,312 +193,120 | +5% | +$3.39M |
|
23
Pacira BioSciences
PCRX
$1.2B
| $62.2M | 1.23% | 1,025,000 | – | – |
|
24
Edwards Lifesciences
EW
$47.8B
| $60.3M | 1.19% | 582,000 | – | – |
|
25
Phreesia
PHR
$1.88B
| $58.8M | 1.16% | 960,000 +110,000 | +13% | +$6.74M |
|